Intra-Cellular Therapies Inc (ITCI) stock saw a decline, ending the day at $126.9 which represents a decrease of $-0.29 or -0.23% from the prior close of $127.19. The stock opened at $127.24 and ...
We recently compiled a list of the 12 High Flying AI Stocks This Week. In this article, we are going to take a look at where ...
JPMorgan has updated its outlook on Primo Brands Corp. (NYSE: PRMB), raising the price target to $38.00 from the previous $33.00, while maintaining an Overweight rating on the company's shares.